Courses
Advance your knowledge in engaging, interactive courses developed and taught by leaders in the field.
Course Types
Browse All MDS Courses
New courses are added regularly.
Sign up for email notifications »
Please wait while we gather your results.
Journal CME 41.07: Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson’s Disease
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001128 <p>The Journal CME 41.07 article aims to investigate the feasibility and acute motor benefit of STN-DBS programming, guided by intraoperatively recorded evoked resonant neural activity (ERNA) in patients with PD.</p> Deep brain stimulation, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Surgical Kanae J. Nagao, MBBS, FRACP 60 1.00 https://education.movementdisorders.org/Detail/1128/Journal-CME-41-07:-Automating-Subthalamic-Deep-Brain-Stimulation-Programming-with-Evoked-Resonant-Neural-Activity-in-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-06-30T00:00:00 2027-06-30T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.07%20-%20Disclosures_30062026101221.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of evoked resonant neural activity (ERNA) in deep brain stimulation programming<br>2. Assess the clinical performance of ERNA-guided programming compared with conventional programming methods<br>3. Evaluate the potential of ERNA-guided programming to improve deep brain stimulation outcomes in Parkinson's disease</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.07-Automating-Subthalamic-Deep-Brain-Stimulation-Programming-with-Evoked-Resonant-Neural-Activity-in-Parkinsons-Disease.htm Journal CME 41.07: Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson’s Disease Journal CME 41.07 2026-06-30T12:00:55.333 0 0 Experienced / Intermediate Journal CME CME English On-Demand USA Clinician Fellow Industry Researcher Resident
Journal CME 41.06: An Open-Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington’s Disease
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001127 <p>The Journal CME 41.06 article aims to eassess the safety, pharmacokinetics (PK), pharmacodynamics, and clinical activity of ANX005 in patients with Huntington’s disease (HD).</p> Chorea/Huntingtons Disease (HD), Clinical Trials, Hyperkinetic Movement Disorders, Therapies-Pharmacological Rajeev Kumar, MD 60 1.00 https://education.movementdisorders.org/Detail/1127/Journal-CME-41-06:-An-Open-Label-Phase-1b-Study-of-the-Safety,-Pharmacokinetics,-Pharmacodynamics,-and-Clinical-Activity-of-ANX005-in-Patients-with-Huntington’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-06-30T00:00:00 2027-06-30T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.06%20-%20Disclosures_30062026092726.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of complement inhibition in Huntington's disease</p><p>2. Assess the safety and preliminary clinical findings of ANX005</p><p>3. Evaluate the potential role of complement biomarkers in guiding Huntington's disease treatment</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.06-An-Open-Label-Phase-1b-Study-of-the-Safety-Pharmacokinetics-Pharmacodynamics-and-Clinical-Activity-of-ANX005-in-Patients-with-Huntingtons-Disease.htm Journal CME 41.06: An Open-Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington’s Disease Journal CME 41.06 2026-06-30T12:00:53.910 0 0 Experienced / Intermediate Journal CME CME English On-Demand USA Clinician Fellow Industry Researcher Resident
Palliative Care in Movement Disorders
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.001119 <span style="line-height:107%;">This module provides an in-depth knowledge about approaches to achieve holistic palliative care in Movement Disorders. The module gives an overview of pharmacological and non-pharmacological approaches used in palliative medicine for patients with Movement Disorders and outlines different strategies to support patients and care partners.</span> Care Models, Palliative care and Hospice Veronica Bruno, MD, MPH 60 1.00 https://education.movementdisorders.org/Detail/1119/Palliative-Care-in-Movement-Disorders https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-48-001-Palliative-care-202x108908985.jpg https://education.movementdisorders.org/Upload/BannerImages/05INTERACT-48-001-Palliative-care-734x404391847.jpg 2026-06-17T00:00:00 2029-06-17T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final%20Disclosure%20Block_Palliative%20Care%20in%20Movement%20Disorders_17062026092124.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Veronica Bruno, MD, MPH - University of Calgary, Calgary, Canada</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Identify the importance of palliative care in movement disorders.</p><p>2. Structure a comprehensive pallaitive care consultation.</p><p>3. Identify and manage common challenges in advanced movement disorders.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Palliative-Care-in-Movement-Disorders.htm Palliative Care in Movement Disorders 2026-06-17T12:01:11.990 0 0 Foundational / Beginner Interactive CME English On-Demand USA Clinician Clinician-General Neurologist Clinician-Movement Disorder Specialist Clinician-Other Clinician-Primary Care Clinician-Researcher Fellow Fellow-Clinical Fellow-Movement Disorders Health Professional Health Professional-Clinical Nurse Specialist Health Professional-Dieticians Health Professional-Music Health Professional-Nurse Health Professional-Nurse Practitioner Health Professional-Occupational Health Professional-Other Health Professional-Physician Assistants Health Professional-Physio / Physical Health Professional-Psychologists Health Professional-Social Work Health Professional-Speech Health Professional-Therapist Resident Resident-Neurology Resident-Other Student-Medical
Journal CME 41.05: Perampanel Blocks Transsynaptic a-Synuclein Propagation and Neurodegeneration in a Mouse Model of Lewy Body Disease
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001120 <p>The Journal CME 41.05 article aims to elucidate the underlying mechanisms of this effect and whether perampanel inhibits transsynaptic α-synuclein propagation.</p> Basic/Translational Neuroscience, Etiology & Pathophysiology, Lewy-body dementia (LBD), Medications for motor symptoms, Medications for non-motor symptoms, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Synucleinopathy, Therapies-Pharmacological Jun Ueda, MD, PhD 60 1.00 https://education.movementdisorders.org/Detail/1120/Journal-CME-41-05:-Perampanel-Blocks-Transsynaptic-a-Synuclein-Propagation-and-Neurodegeneration-in-a-Mouse-Model-of-Lewy-Body-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-06-05T00:00:00 2027-06-05T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.05%20-%20Disclousers_04062026015555.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong><br>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.<br><strong><br>LEARNING OBJECTIVES</strong><br>Upon completion of this activity, learners will be able to:<br>1. Understand the role of transsynaptic α-synuclein propagation and dynamin-dependent endocytosis in the progression of Lewy body disease<br>2. Assess the effects of perampanel on α-synuclein uptake, pathology spread, and neurodegeneration in preclinical models<br>3. Evaluate the potential of perampanel as a disease-modifying therapeutic strategy for Lewy body disease<br><strong><br>INTENDED AUDIENCE</strong><br>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.<br><br><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong><br>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.<br>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).<br>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.<br>4. Adobe Flash Player 12.0 (or higher).<br>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.05-Perampanel-Blocks-Transsynaptic-a-Synuclein-Propagation-and-Neurodegeneration-in-a-Mouse-Model-of-Lewy-Body-Disease.htm Journal CME 41.05: Perampanel Blocks Transsynaptic a-Synuclein Propagation and Neurodegeneration in a Mouse Model of Lewy Body Disease Journal CME 41.05 2026-06-08T09:01:13.170 0 0 Experienced / Intermediate Journal CME CME English On-Demand USA Clinician Fellow Industry Researcher Resident
Journal CME 41.04: Mapping Regional Brain Aging in Huntington's Disease Using Structural Magnetic Resonance Imaging and Machine Learning
On Demand
Journal CME
60 Minutes
Foundational / Beginner
CME Credits:1.001116 <p>The Journal CME 41.04 article aims to characterize region specific patterns of brain aging across Huntington’s Disease Integrated Staging System (HD-ISS) stages and evaluate their associations with cognitive, motor, and functional scores.</p> Biomarkers, Biomarkers & Diagnostic Tools, Chorea/Huntingtons Disease (HD), Hyperkinetic Movement Disorders, Neuroimaging Mohsen Ghofrani-Jahromi, PhD 60 1.00 https://education.movementdisorders.org/Detail/1116/Journal-CME-41-04:-Mapping-Regional-Brain-Aging-in-Huntington's-Disease-Using-Structural-Magnetic-Resonance-Imaging-and-Machine-Learning https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-06-05T00:00:00 2027-06-05T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.04%20-%20Disclosures_03062026105825.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand regional patterns of accelerated brain aging across Huntington's disease stages</p><p>2. Assess the associations between regional brain age gaps and cognitive, motor, and functional outcomes in Huntington's disease</p><p>3. Evaluate the potential of region-specific brain age measures as biomarkers for monitoring disease progression and treatment effects</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.04-Mapping-Regional-Brain-Aging-in-Huntingtons-Disease-Using-Structural-Magnetic-Resonance-Imaging-and-Machine-Learning.htm Journal CME 41.04: Mapping Regional Brain Aging in Huntington's Disease Using Structural Magnetic Resonance Imaging and Machine Learning Journal CME 41.04 2026-06-08T09:01:10.593 0 0 Foundational / Beginner Journal CME CME English On-Demand USA Clinician Fellow Industry Researcher Resident
MDS Case Presentation: The Venn Diagram of Movement Disorders, Epilepsy and Genetics
On Demand
Case Presentation Series
15 Minutes
Foundational / Beginner
944 This brief 15 minute case presentation will provide the learner with an opportunity to accept the role of a decisive clinician regarding a clinical case involving movement disorders, epilepsy, and genetics. Basal Ganglia, Biomarkers, Biomarkers & Diagnostic Tools, Drug-induced Movement Disorders/Tardive dyskinesia, Dystonia, Etiology & Pathophysiology, Genetic & Hereditary Disorders, Genetics, Hyperkinetic Movement Disorders, Medications for motor symptoms, Neuroimaging, Neuropathology, Other Movement Disorders, Rating Scales, Therapies-Pharmacological Darius Ebrahimi-Fakhari, MD, PhD 15 0.00 https://education.movementdisorders.org/Detail/944/MDS-Case-Presentation:-The-Venn-Diagram-of-Movement-Disorders,-Epilepsy-and-Genetics https://education.movementdisorders.org/Upload/ActivityImages/Case-based-Series866197.jpg 2026-05-20T00:00:00 2029-05-20T00:00:00 MDS Education <p><strong>FACULTY</strong></p><p>Darius Ebrahimi-Fakhari, MD, PhD - Boston Children's Hospital, Boston, MA, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Develop a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/MDS-Case-Presentation-The-Venn-Diagram-of-Movement-Disorders-Epilepsy-and-Genetics.htm MDS Case Presentation: The Venn Diagram of Movement Disorders, Epilepsy and Genetics 2026-05-20T00:01:45.550 0 0 Foundational / Beginner Case Presentation Series English On-Demand USA Clinician Clinician-Primary Care Fellow Health Professional Industry Resident Student
MDS Case Presentation: Freezing of Gait (FOG) Considerations for Personalized Rehabilitation in Parkinson’s Disease
On Demand
Case Presentation Series
15 Minutes
Foundational / Beginner
942 This brief 15 minute case presentation will provide the learner with an opportunity to accept the role of a decisive clinician regarding a clinical case involving a patient with freezing of gait. Care Models, Freezing of Gait (FOG), Occupational Therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Physical Medicine and Rehabilitation, Physical Therapy/Physiotherapy, Therapies-Other Becky Farley, PhD, MS, PT 15 0.00 https://education.movementdisorders.org/Detail/942/MDS-Case-Presentation:--Freezing-of-Gait-(FOG)-Considerations-for-Personalized-Rehabilitation-in-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/Case-based-Series866197.jpg 2026-04-15T00:00:00 2029-04-15T00:00:00 MDS Education <p><strong>FACULTY</strong></p><p>Becky Farley, PhD, MS, PT - Parkinson Wellness Recovery, Tucson, AZ, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Develop a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/MDS-Case-Presentation--Freezing-of-Gait-FOG-Considerations-for-Personalized-Rehabilitation-in-Parkinsons-Disease.htm MDS Case Presentation: Freezing of Gait (FOG) Considerations for Personalized Rehabilitation in Parkinson’s Disease 2026-04-20T12:00:57.703 0 0 Foundational / Beginner Case Presentation Series English On-Demand USA Clinician Clinician-Primary Care Fellow Health Professional Industry Resident Student
Journal CME 41.03: Parkinson’s-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001088 <p>The Journal CME 41.03 article aims to test the hypothesis that LRRK2 and GBA modify the human peripheral immune response to bacteria, specifically P. aeruginosa, based on prior animal studies involving Lrrk2 mutations and microbial pathogens.</p> Autoimmune, Basic/Translational Neuroscience, Environmental Risk factors, Etiology & Pathophysiology, Genetics, Neuropathology, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD) Julian R. Mark 60 1.00 https://education.movementdisorders.org/Detail/1088/Journal-CME-41-03:-Parkinson’s-Linked-LRRK2-and-GBA1-Mutations-Modulate-the-Peripheral-Immune-Response-to-Pseudomonas-aeruginosa https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-03-18T00:00:00 2027-03-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.03%20-%20Disclosures_17032026110315.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Evaluate the impact of LRRK2 and GBA1 mutations on peripheral immune responses in Parkinson’s disease</p><p>2. Assess the effects of LRRK2 inhibition and glucocerebrosidase activation on cytokine signaling and immune cell function</p><p>3. Understand mechanisms linking peripheral immune dysregulation to Parkinson’s disease pathogenesis</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.03-Parkinsons-Linked-LRRK2-and-GBA1-Mutations-Modulate-the-Peripheral-Immune-Response-to-Pseudomonas-aeruginosa.htm Journal CME 41.03: Parkinson’s-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa Journal CME 41.03 2026-03-18T12:01:06.157 0 0 Experienced / Intermediate Journal CME CME English On-Demand USA Clinician Fellow Industry Researcher Resident
MDS Case Presentation: A 4-Year-Old With Spells of Inbalance
On Demand
Case Presentation Series
15 Minutes
Foundational / Beginner
943 This brief 15 minute case presentation will provide the learner with an opportunity to accept the role of a decisive clinician regarding a clinical case of a 4 year-old patient with spells of inbalance. Biomarkers, Biomarkers & Diagnostic Tools, Care Models, Dystonia, Gait & Balance Disorders, Genetic & Hereditary Disorders, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Nutritional Therapy, Other Movement Disorders, Pediatrics, Rating Scales, Therapies-Other Claudio M. De Gusmao, MD, PhD 15 0.00 https://education.movementdisorders.org/Detail/943/MDS-Case-Presentation:-A-4-Year-Old-With-Spells-of-Inbalance https://education.movementdisorders.org/Upload/ActivityImages/Case-based-Series866197.jpg https://education.movementdisorders.org/Upload/BannerImages/caseimg746707.jpg 2026-03-17T00:00:00 2029-03-17T00:00:00 MDS Education <p><strong>FACULTY</strong></p><p>Claudio M. De Gusmao, MD, PhD - Mass General Brigham/Harvard Medical School, Boston, MA, United States</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Develop a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/MDS-Case-Presentation-A-4-Year-Old-With-Spells-of-Inbalance.htm MDS Case Presentation: A 4-Year-Old With Spells of Inbalance 2026-03-17T03:00:51.610 0 0 Foundational / Beginner Case Presentation Series English On-Demand USA Clinician Clinician-Primary Care Fellow Health Professional Industry Resident Student
Journal CME 41.02: Polyelectromyography Under Propofol to Differentiate Functional from Idiopathic Dystonia: A Pilot Study
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001076 <p>The Journal CME 41.02 article aims to investigate potential differences in muscle activity between ID and FD patients using polyelectromyography (PEMG) under anesthesia.</p> Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Functional Movement Disorders, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Other Movement Disorders, Rating Scales Roberto Eleopra, MD 60 1.00 https://education.movementdisorders.org/Detail/1076/Journal-CME-41-02:-Polyelectromyography-Under-Propofol-to-Differentiate-Functional-from-Idiopathic-Dystonia:-A-Pilot-Study https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-02-19T00:00:00 2027-02-19T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.02%20-%20Disclosures_16022026081618.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the diagnostic overlap between functional and idiopathic dystonia and the need for objective biomarkers</p><p>2. Evaluate the role of sedation-based PEMG findings in differentiating FD from ID</p><p>3. Assess the clinical utility and limitations of EMG patterns under anesthesia in the diagnostic workup of dystonia</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.02-Polyelectromyography-Under-Propofol-to-Differentiate-Functional-from-Idiopathic-Dystonia-A-Pilot-Study.htm Journal CME 41.02: Polyelectromyography Under Propofol to Differentiate Functional from Idiopathic Dystonia: A Pilot Study Journal CME 41.02 2026-02-19T09:01:11.360 0 0 Experienced / Intermediate Journal CME CME English On-Demand USA Clinician Fellow Industry Researcher Resident
Many MDS courses are free or offer need-based assistance. MDS members receive reduced rates.
View each couse's details for rates and available grant opportunities.
Popular Courses
A Comprehensive Review of Movement Disorders for the Clinical Practitioner
"As a rite of passage, every movement disorder fellow must pass through the Aspen course."
“The Aspen Course” has been the foundation for movement disorders education for more than 30 years, providing a broad but in-depth overview of the field's core concepts. Learn from and network alongside the foremost leaders in the field.
School for Young Neurologists
A prestigious opportunity to learn from the foremost experts and gain the knowledge, practical skills, and connections that can shape your career.
Offered annually in each region.
School for Neurology Residents
Acclaimed 2-day introduction to the vast opportunities across the growing and rapidly advancing field of Movement Disorders.
eLearning Module Categories
New interactive, on-demand modules are added regularly.
Please wait while we gather your results.
Fundamentals
Interactive
Case Presentations
Journal CME
Device-Assisted Therapies
Coffee Break CME
Have a topic suggestion?
To ensure that MDS education covers a broad range of timely, relevant local topics, MDS Members are annually invited to submit suggestions for consideration by the Regional Education Committees.
Topic suggestions open every June, and will be sent to members via email.